newsfilter
← Latest News
GlobeNewswire·

vTv Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Phase 3 CATT1 completion of enrollment on track for the third quarter of 2026 Strong balance sheet expected to fund operations through anticipated CATT1 topline data readout HIGH POINT, N.C., May 13, 2026 (GLOBE